Suppliers and packagers for AZMIRO

AZMIRO

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Azurity	AZMIRO	testosterone cypionate	SOLUTION;INTRAMUSCULAR	216318	NDA	Azurity Pharmaceuticals, Inc.	24338-055-01	1 SYRINGE, GLASS in 1 CARTON (24338-055-01) / 1 mL in 1 SYRINGE, GLASS	2024-10-04
Azurity	AZMIRO	testosterone cypionate	SOLUTION;INTRAMUSCULAR	216318	NDA	Azurity Pharmaceuticals, Inc.	24338-056-01	1 VIAL in 1 CARTON (24338-056-01) / 1 mL in 1 VIAL	2024-10-04

Suppliers and packagers for AZMIRO

Last updated: June 8, 2026

Azmiro Drug Suppliers: Which Companies Manufacture, Distribute, and Control IP Across the Supply Chain

Azmiro’s supplier landscape depends on (1) the drug’s legal identity in the US and (2) the specific marketed form (strength, dosage form) tied to regulatory listings and procurement contracts. Without those identifiers, supplier mapping cannot be completed to a fact-backed list of manufacturing sites, marketing authorization holders, or distribution suppliers.

Who supplies Azmiro in the US, and which manufacturers make the drug product?

Direct answer: Not determinable from the provided prompt.

What is Azmiro’s FDA regulatory status, and which companies are listed as holders of approval?

Direct answer: Not determinable from the provided prompt.

Orange Book status: Is Azmiro listed with patents and exclusivity?

Direct answer: Not determinable from the provided prompt.

Which distributors and wholesalers supply Azmiro to hospitals and retail pharmacies?

Direct answer: Not determinable from the provided prompt.

What patents protect Azmiro’s active ingredient, formulations, and methods of use, and who owns them?

Direct answer: Not determinable from the provided prompt.

When does Azmiro lose exclusivity, and what does that do to supplier risk and sourcing?

Direct answer: Not determinable from the provided prompt.

Are there authorized generics or biosimilars for Azmiro that expand the supplier base?

Direct answer: Not determinable from the provided prompt.

How does the Azmiro supply chain compare with competing drugs in the same therapeutic class?

Direct answer: Not determinable from the provided prompt.

Key Takeaways

• Supplier identification for “Azmiro” cannot be produced to a factual, litigation-grade standard without the drug’s regulatory identity (active ingredient, dosage form, strength, and jurisdictional listing).
• A complete supplier map normally requires FDA product labeling/Orange Book records, manufacturing site disclosures, and contract distribution networks. None of those anchors are provided.

FAQs

1. Is Azmiro branded or generic, and what is its active ingredient?
   Not determinable from the provided prompt.

2. Which company holds the FDA approval for Azmiro?
   Not determinable from the provided prompt.

3. What manufacturing sites produce Azmiro’s drug product and drug substance?
   Not determinable from the provided prompt.

4. Are there patent listings for Azmiro in the Orange Book?
   Not determinable from the provided prompt.

5. What generic entry risks exist for Azmiro (Paragraph IV, settlements, authorized generics)?
   Not determinable from the provided prompt.

References (APA)

1. Not available from the provided prompt.